Previous 10 | Next 10 |
Are These Penny Stocks on Your December Watchlist? In December 2021, there is a sizable amount of bullish sentiment with penny stocks. As a result of the sheer number of factors impacting the stock market, those who know how to trade penny stocks can take advantage. Right now, the m...
SEATTLE, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces that it ...
Are These Reddit Penny Stocks on Your List Right Now? If you’re looking for the best penny stocks to buy on Reddit, there’s no better time than right now. As a result of the major movement that is occurring in the stock market, there are plenty of opportunities to make m...
SEATTLE, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announces that Atossa’...
Atossa Therapeutics (NASDAQ:ATOS): Q3 GAAP EPS of -$0.04 beats by $0.02. Press release For the quarter ended September 30, 2021, Atossa has no source of sustainable revenue and no associated cost of revenue. As of September 30, 2021, the Company had cash, cash equivalents and restricted cash ...
SEATTLE, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to develop innovative proprietary medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, today announces financia...
SEATTLE, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Dr. Steven Quay, CEO of Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a ...
SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need in oncology and infectious diseases with a current focus on breast...
4 Active Penny Stocks to Watch in September 2021 Finding the most active penny stocks is a great way to find potential winners in the stock market. However, there are plenty of other factors to consider when making your decision. But before we get into that, let’s look at stock m...
Atossa Therapeutics is clinical-stage biotech whose stock has trended a highly volatile path during the last one-year period. In addition to breast cancer research, where the company has been involved for years, it also focuses on producing nasal drops and inhalation therapy for comba...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...